Nevertheless, increased expression of NKG2A led to the reduced levels of CD107a (degranulation marker), IFN-γ, IL-2, granzyme B, and TNF-α in NK cells from COVID-19 patients (53). This evidence concerns the gene GZMB and COVID-19.